Sunshine Holdings PlcCSELK: SUN.N0000

Condensed interim consolidated financial statements for the quarter ended 31st March 2025

· Issued by Sunshine Holdings PLC
SUNSHINE HOLDINGS PLC

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED

31st March 2025



SUNSHINE HOLDINGS PLC

GROUP CHIEF EXECUTIVE OFFICER'S MESSAGE

Dear Shareholders,

FY25 marked a year of resilience and renewed momentum for Sunshine Holdings PLC, as we delivered steady top-line growth while continuing to invest in the long-term transformation of our core businesses. Despite macroeconomic headwinds and evolving consumer dynamics, the Group achieved strong financial results and laid critical groundwork for sustained value creation.

The Group posted a consolidated revenue of LKR 59.3 bn for FY25, reflecting a 7.0% year-on-year (YoY) growth. This performance was led by strong double-digit expansion in the Healthcare segment, which contributed 55.0% of Group revenue. The Consumer and Agribusiness sectors accounted for 31.6% and 13.4% of revenue, respectively, maintaining a balanced and diversified portfolio.

Gross profit grew 6.6% YoY to LKR 17.8 bn, with the gross margin holding steady at 30.1% in FY25 cf. 30.2% in FY24, reflecting the resilience of core operations. Increased scale in the Healthcare sector and operational efficiencies in Agribusiness supported profitability, with earnings before interest and taxes (EBIT) rising to LKR 9.3 bn, a 7.1% increase YoY. The Group maintained an EBIT margin of 15.7%, despite margin contraction in the Consumer segment.

Profit after tax (PAT) reached LKR 5.9 bn, broadly flat versus last year -1.7% YoY despite a 48.9% increase in income tax expenses stemming from changes in Agribusiness taxation, and continued margin pressures in the Consumer segment.

Financial Snapshot

4QFY25 Vs 4QFY24 FY25 Vs FY24

Following the FY25 share split (4-for-1), which improved liquidity and broadened investor access, the Group will continue to engage with the capital markets actively, with a commitment to transparency, shareholder returns, and long-term value generation.

Healthcare

7,804

15.9%

32,586

17.3%

Consumer

4,373

-2.6%

18,747

-3.0%

Agri

1,919

4.4%

7,944

-4.5%

Other

2

n/m

5

2.3%

Revenue

14,097

7.9%

59,282

7.0%

Gross Profit

3,921

13.1%

17,848

6.6%

GP Margin

27.8%

+128 bps

30.1%

-10 bps

EBIT

1,887

48.7%

9,278

7.1%

EBIT Margin

13.4%

+367 bps

15.7%

+2 bps

Net Finance Cost

(79)

-74.2%

(308)

-47.9%

Income Tax Expense

(576)

47.2%

(3,057)

48.9%

PAT

1,232

116.1%

5,914

-1.7%

Healthcare

The Healthcare sector continued its trajectory of robust growth, recording double-digit revenue growth of 17.3% YoY across the pharmaceutical agency, distribution, and pharmaceutical manufacturing verticals. This topline momentum translated into improved profitability, with the sector's EBIT margin expanding to 16.9% in FY25, up from 15.5% in FY24.

The pharmaceutical agency business delivered a strong 14.3% YoY growth, fueled by sustained volume expansion across key therapeutic areas. The medical devices segment contracted by 12.8% YoY, reflecting a high base in the prior year. Adjusting for this, the underlying business posted 5.2% YoY growth, underscoring continued demand and stability in core device categories.

Healthguard Distribution expanded its portfolio by securing new distributor relationships with Cipla and Micro Labs, contributing to a 23.9% revenue increase in FY25. These partnerships are expected to bring long-term value through increased distribution capabilities, and joint business development initiatives.

Our retail arm, Healthguard Pharmacy, recorded 9.2% revenue growth YoY, driven primarily by increased prescription volumes in the pharmaceutical category. The wellness segment also contributed through value growth, despite a slight decline in volumes, reflecting stronger average spend per customer. During the year, we expanded our retail footprint to 16 outlets with the opening of a new location in Malabe, extending our reach into high-growth suburban areas.

Lina, the pharmaceutical manufacturing business, continued to scale meaningfully with a 69.2% YoY increase in revenue. This performance was led by higher output from the Metered Dose Inhaler (MDI) line, which fulfilled the entirety of the Government's MDI requirement for 2024. Lina's ability to deliver critical respiratory products at scale further reinforces its role as a key enabler of local pharmaceutical self-sufficiency.

Consumer

The Consumer sector, comprising both export and domestic businesses, faced a challenging year, with revenue contracting by 3.0% YoY to LKR 18.7 bn, primarily due to subdued domestic demand during the first half of FY25.

Revenue from the Branded Tea and Confectionery (domestic) businesses declined by 12.7% YoY.

While the branded tea segment demonstrated resilience, confectionery volumes remained under pressure throughout the year.

Within branded tea, volumes grew by 2.2% YoY during the year, despite an 8.8% contraction in value, primarily due to VAT related pricing pressures in the first half. Amidst challenging consumer sentiment, our tea brands Watawala Thei and Ran Kahata showed resilience, though Zesta experienced a volume decline during the period.

The confectionery segment continued to be affected by weak consumer sentiment following VAT increases, alongside intensified competitive activity. These pressures contributed to a significant volume drop, translating into a 28.0% YoY revenue contraction for FY25.

However, this was partially offset by the export business, which maintained its positive momentum in FY25. Strong demand from key clients supported volume growth, resulting in a 19.1% YoY increase in export revenue.

EBIT margins for the sector came under pressure in FY25, impacted by adverse market conditions in the first half and a normalization following favorable conditions in FY24. As a result, margins contracted to 6.1%, compared to 9.7% in the previous year.

Agribusiness

The Agribusiness sector reported revenue of LKR 7.9 bn in FY25, a 4.5% decline YoY, attributable to an 18.6% drop in revenue from the dairy business.

The palm oil segment saw a 1.6% YoY decline in revenue, primarily due to lower sales volumes. While selling prices for oil and crops improved in the second half of the year, this was

Page 01



SUNSHINE HOLDINGS PLC

insufficient to offset the impact of reduced volumes.

The dairy business recorded LKR 1.2 bn in revenue, down 18.6% YoY, driven by reductions in both production volumes and realized selling prices.

Despite the topline contraction, sector profitability improved, with EBIT margin increasing to 36.2% in FY25, compared to 32.0% in the previous year. This uplift was driven by cost efficiencies in the palm oil segment.

Outlook

Healthcare: Following the successful equity infusion from the International Finance Corporation (IFC), the Group will continue to accelerate the scale-up of operations at Sunshine Healthcare Lanka (SHL). Strategic investments are underway to expand Lina's manufacturing capacity, strengthen diagnostic infrastructure, and deepen retail and distribution reach. The sector remains focused on delivering accessible, high-quality healthcare while pursuing selective organic and inorganic growth opportunities across its core verticals. Continued operational discipline and innovation will be key to unlocking further efficiencies and expanding market share in FY26.

Consumer: The Group will maintain its strategic emphasis on strengthening consumer brand equity and improving route-to-market execution. While domestic demand is expected to remain sensitive to pricing, ongoing investments in product innovation and retail channel synergies will help defend market share. The export business will continue to be a primary growth engine, with efforts underway to further diversify markets and scale volumes.

Agribusiness: The Agribusiness sector is poised for a more stable year, with palm oil prices expected to remain steady and volumes increasing with greater focus on land productivity. In the dairy business, more favourable feed economics are expected to support margins.

Further details of the Group's performance are available on the

company website.

https://www.sunshineholdings.lk/investor/financial-reports



Shyam Sathasivam

Group Chief Executive Officer 28 May 2025

Colombo

Page 02



SUNSHINE HOLDINGS PLC

CONDENSED STATEMENT OF COMPREHENSIVE INCOME - GROUP

Unaudited

*Restated

Audited

Unaudited

*Restated

Unaudited

Year ended

Year ended

Year ended

Quarter ended

Quarter ended

Quarter ended

31

31

31

31

31

31

March

March

March

March

March

March

2025

2024

2024

Change

2025

2024

2024

Change

RS '000

RS '000

RS '000

%

RS '000

RS '000

%

Continuing operations

Revenue

59,282,247

55,422,147

55,533,886

7

14,097,237

13,065,554

13,148,167

8

Cost of sales

(41,434,404)

(38,680,900)

(38,293,643)

7

(10,176,431)

(9,599,468)

(9,518,011)

6

Gross profit

17,847,843

16,741,247

17,240,243

7

3,920,806

3,466,086

3,630,156

13

Dividend Income

61,303

111,740

-

12,680

82,613

-

(85)

Other income

589,893

326,417

315,094

81

286,780

5,978

(5,343)

nm

Gain/(loss) on changes in fair

value of biological assets

(321,221)

39,989

39,989

nm

(68,168)

53,629

53,629

nm

Selling & distribution expenses

(5,325,073)

(5,260,705)

(5,260,705)

1

(1,318,500)

(1,425,308)

(1,425,308)

(7)

Administrative expenses

(3,574,283)

(3,296,296)

(3,672,230)

8

(946,781)

(914,320)

(984,456)

4

Results from operating activities

9,278,462

8,662,392

8,662,392

7

1,886,817

1,268,678

1,268,678

49

Finance income

503,253

577,588

577,588

(13)

111,629

940

940

nm

Finance cost

(810,870)

(1,168,094)

(1,168,094)

(31)

(191,003)

(308,402)

(308,402)

(38)

Net finance cost

(307,617)

(590,506)

(590,506)

(48)

(79,374)

(307,462)

(307,462)

(74)

Profit before tax 8,970,845

8,071,886

8,071,886

11

1,807,443

961,216

961,216

88

Income tax expense (3,056,720)

(2,052,638)

(2,052,638)

49

(575,500)

(391,062)

(391,063)

47

Profit for the period 5,914,125

6,019,248

6,019,248

(2)

1,231,943

570,153

570,153

116

Other comprehensive income

Equity investments at FVOCI -

net change - in fair value (216,354)

360,558

360,558

(160)

(216,354)

360,558

360,558

-

Exchange gain/(Loss) on

foreign operation translation (410)

(3,335)

(3,335)

(88)

323

(2,210)

(2,210)

-

Tax on other comprehensive

income 104,980

(101,089)

(101,089)

(204)

104,980

(101,089)

(101,089)

Remeasurement of retirement

benefit liability (136,998)

(24,249)

(24,249)

465

(136,998)

(24,249)

(24,249)

-

income for the period (248,782)

231,885

231,885

(207)

(248,049)

233,010

233,010

-

Total comprehensive income

for the period 5,665,344

6,251,133

6,251,133

(9)

983,894

803,163

803,163

23

Profit aflributable to:

Owners of the parent company 4,239,533

4,471,041

4,471,041

(5)

877,140

508,197

508,197

73

Non-controlling interest 1,674,593

1,548,206

1,548,206

8

354,803

61,955

61,955

473

Other comprehensive income aflributable to:

Owners of the parent company (201,252)

238,670

238,670

(184)

(200,519)

239,796

239,796

(184)

Non-controlling interest (47,530)

(6,785)

(6,785)

-

(47,530)

(6,785)

(6,785)

Total comprehensive income

5,665,344

6,251,133

6,251,133

(9)

983,894

803,163

803,163

23

Basic earnings per share 2.15

2.27

2.27

0.45

0.26

0.26

Total other comprehensive

for the period

Figures in brackets indicate deductions.

The above figures are not audited n/m- not meaningful

* 2024 Figures have been reclassięed according to SLFRS 15 as a result of the business module change. Detailed note has provided in Note no 06.

Page 03



SUNSHINE HOLDINGS PLC

CONDENSED STATEMENT OF COMPREHENSIVE INCOME - COMPANY

**Amalgamated and

**Amalgamated

Unaudited

*Restated

Restated

Audited

Unaudited

*Restated

and Restated

Unaudited

Year ended

Year ended

Year ended

Period ended

Quarter ended

Quarter ended

Quarter ended

Quarter ended

31 March

31 March

31 March

31 March

31 March 2025

31 March 2024

31 March 2024

31 March 2024

Change

2025

2024

2024

2024

Change

RS '000

RS '000

RS '000

RS '000

%

RS '000

RS '000

RS '000

RS '000

%

Revenue

749,840

452,869

475,158

2,070,290

58

197,436

121,075

126,841

507,665

56

Cost of sales

(730,870)

(387,258)

(387,258)

-

89

(248,002)

(83,668)

(83,667)

-

196

Gross profit

18,970

65,611

87,900

2,070,290

(78)

(50,565)

37,408

43,174

507,665

(217)

Dividend income

2,395,266

2,070,290

2,070,290

-

16

427,282

507,664

507,664

-

(16)

Other income

129,410

48,421

50,364

489,969

157

86,653

20,402

21,265

130,156

307

Administrative expenses

(424,765)

(367,982)

(359,349)

(743,919)

13

(94,974)

(196,089)

(182,310)

(268,434)

(52)

Results from operating activities

2,118,881

1,816,340

1,849,206

1,816,340

16

368,396

369,386

389,792

369,385

(2)

Finance income

96,212

159,616

139,246

159,616

(31)

27,406

40,800

33,179

40,800

(17)

Finance cost

(4,321)

(1,217)

(1,217)

(1,217)

255

503

(45)

(45)

(46)

(1,214)

Net finance cost 91,891

158,399

138,028

158,399

(33)

27,909

40,755

33,134

40,754

(16)

Profit before tax 2,210,772

1,974,739

1,987,234

1,974,739

12

396,308

410,140

422,925

410,139

(3)

Income tax expense 32,923

17,289

17,289

17,289

90

32,299

10,602

10,602

10,602

205

Profit for the period 2,243,695

1,992,029

2,004,523

1,992,029

13

428,608

420,742

433,527

420,741

2

Other comprehensive income

Equity investments at FVOCI - net change (216,354)

in fair value

360,558

360,558

360,558

-

(216,354)

360,558

360,558

360,558

-

Relax Tax 61,853

(105,565)

(105,565)

(105,565)

-

61,853

(105,565)

(105,565)

(105,565)

-

Defined benefit plan actuarial gain/(loss) 10,176

(8,673)

(8,673)

(8,673)

-

10,176

(8,673)

(8,673)

(8,673)

-

Total other comprehensive income for the period (144,325)

246,320

246,320

246,320

-

(144,325)

246,320

246,320

246,320

-

Total comprehensive income for the period 2,099,370

2,238,349

2,250,843

2,238,349

(6)

284,283

667,062

679,847

667,061

(57)

Basic earnings per share from continuing operations 1.14

1.01

1.02

1.01

0.22

0.21

0.22

0.21

Figures in brackets indicate deductions.

* 2024 Figures have been reclassified according to SLFRS 15 as a result of the business module change. Detailed note has provided in Note no 06.

** Sunshine Packaging lanka Limited has amalgamated with Sunshine Holdings PLC and figures prasented accordingly. Detailed note has provided in Note no 7.5.

Page 04



SUNSHINE HOLDINGS PLC

STATEMENT OF FINANCIAL POSITION - GROUP

Unaudited Audited

As at 31st March 2025

RS '000

As at 31st March 2024

RS '000

ASSETS

Non current assets

Property, plant and equipment

6,828,565

6,641,907

Intangible assets

235,132

277,903

Leasehold right to bare land

409,805

359,851

Biological assets

3,317,573

3,658,653

Investment property

570,199

631,212

Other investments

578,045

833,617

Deferred tax assets

374,924

420,127

Goodwill on Acquisition

1,310,733

1,387,106

Total non-current assets

13,624,976

14,210,376

Current assets

Biological assets-growing crops on bearer plants

36,510

70,867

Inventories

13,860,452

12,063,288

Other investments

4,489,534

1,770,256

Current tax assets

143,552

139,136

Trade & other receivables

9,796,632

9,782,520

Amounts due from related parties

326,356

31,747

Cash & cash equivalent

5,875,414

5,403,789

Total current assets

34,528,450

29,261,603

Total assets

48,153,426

43,471,979

EQUITY AND LIABILITIES

Equity

Stated capital

4,240,394

4,240,394

Reserves

92,933

430,473

Retained earnings

15,965,699

14,233,958

Equity aflributable to owners of the company

20,299,026

18,904,825

Non-controlling interests

6,748,189

3,767,868

Total equity

27,047,215

22,672,693

Non-current liabilities

Loans and borrowings

1,948,938

1,676,016

Employee benefits

1,221,861

1,009,377

Deferred income and capital grants

34,173

36,726

Deferred tax

1,610,069

1,686,737

Total non-current liabilities

4,815,041

4,408,856

Current liabilities

Trade and other payables

9,209,949

7,603,511

Current tax liabilities

1,410,124

785,681

Loans and borrowings

4,921,953

5,311,993

Bank overdraft

749,144

2,689,245

Total current liabilities

16,291,170

16,390,430

Total equity and liabilities

48,153,426

43,471,979

Net asset value per share (Rs.)

10.32

9.61

The above figures are not audited

It is certified that the Financial Statements have been prepared in compliance with the requirements of the Companies

Act No. 7 of 2007.



Group Chief Financial Officer





The Board of Directors is responsible for the preparation and presentation of these financial statements. Approved and signed for and on behalf of the Board.

Chairman Group Chief Executive Officer

May 28th, 2025

Colombo

Page 05



SUNSHINE HOLDINGS PLC

STATEMENT OF FINANCIAL POSITION - COMPANY

Unaudited

**Amalgamated

Audited

As at 31 March

2025

As at 31 March

2024

As at 31 March

2024

RS '000

RS '000

RS '000

ASSETS

Non-current assets

Property, Plant and Equipment

61,714

8,652

8,652

Intangible assets

9,796

14,490

14,490

Investment property

901,730

845,658

-

Investment in subsidiaries

7,325,815

7,325,815

7,747,698

Other investments

572,918

782,224

782,224

Deferred tax assets

14,689

31,602

31,602

Total non-current assets

8,886,662

9,008,441

8,584,666

Current assets

Inventories

-

296

296

Current tax assets

97,667

75,566

75,566

Trade & other receivables

18,193

72,132

44,017

Amounts due from related parties

9,459

26,192

257,990

Other Short Term Investments

1,890,123

846,226

846,226

Cash & cash equivalent

288,928

734,571

723,291

Total current assets

2,304,370

1,754,983

1,947,386

Total assets

11,191,032

10,763,424

10,532,052

EQUITY AND LIABILITIES

Equity

Stated capital

4,240,394

4,240,394

4,240,394

Reserves

286,264

430,590

430,590

Retained earnings

6,211,099

5,689,313

5,572,519

Equity aflributable to owners of the company

10,737,757

10,360,297

10,243,503

Non-controlling interests

-

-

-

Total equity

10,737,757

10,360,297

10,243,503

Non-current liabilities

Loans and borrowings

-

-

-

Deferred tax liability

-

111,689

-

Employee benefits

229,653

190,922

190,922

Total non-current liabilities

229,653

302,611

190,922

Current liabilities

Trade and other payables

193,857

100,234

97,345

Amounts due to related parties

2

282

282

Loans and borrowings

29,763

-

-

Total current liabilities

223,622

100,516

97,627

Total equity and liabilities

11,191,032

10,763,424

10,532,052

Net asset value per share (Rs.)

5.46

5.26

5.21

The above figures are not audited

** Sunshine Packaging lanka Limited has amalgamated with Sunshine Holdings PLC and figures prasented accordingly. Detailed note has provided in Note no 7.5.



It is certified that the Financial Statements have been prepared in compliance with the requirements of the Companies Act No. 7 of 2007.

Group Chief Financial Officer





The Board of Directors is responsible for the preparation and presentation of these financial statements. Approved and signed for and on behalf of the Board.

Chairman Group Chief Executive Officer

May 28th, 2025 Colombo

Page 06



SUNSHINE HOLDINGS PLC

FOR THE QUARTER ENDED 31ST MARCH 2025

CONDENSED STATEMENT OF CHANGES IN EQUITY - GROUP

Aflributable to owners of the company

In RS '000

Stated capital

Reserve on

exchange gain or

loss

General reserve

Fair value gain

or loss reserve

on AFS

Retained earnings

Total

Non-controlling

interest

Total equity

Balance as at 1st April 2023

4,240,394

4,935

1,258

185,609

11,356,302

15,788,499

3,448,610

19,237,110

Total Comprehensive Income

Profit for the year

-

-

-

-

4,471,041

4,471,041

1,548,206

6,019,247

Total other comprehensive income for the year

-

(3,335)

-

242,006

-

238,670

(6,785)

231,885

Total comprehensive income for the year

-

(3,335)

-

242,006

4,471,041

4,709,711

1,541,421

6,251,132

Dividend paid to owners for 2022/23

-

-

-

-

(565,770)

(565,770)

-

(565,770)

Dividend paid to owners for 2023/24

-

-

-

-

(491,974)

(491,974)

(1,365,219)

(1,857,193)

WHT payment on dividend distribution

-

-

-

-

(438,724)

(438,724)

(46,862)

(485,586)

Lina Manufacturing (Pvt) Ltd and Lina Spiro (Pvt) Ltd Share Swap

-

-

-

-

(96,918)

(96,918)

189,918

93,000

Balance as at 31st March 2024

4,240,394

1,600

1,258

427,615

14,233,958

18,904,825

3,767,868

22,672,693

Balance as at 1st April 2024

4,240,394

1,600

1,258

427,615

14,233,958

18,904,825

3,767,868

22,672,693

Total Comprehensive Income

Profit for the year

-

-

-

4,239,533

4,239,533

1,674,593

5,914,125

Total other comprehensive income for the year

(410)

-

(200,842)

-

(201,252)

(47,530)

(248,782)

Total comprehensive income for the year

Dividend paid to owners for 2023/24

(410)

-

-

(200,842)

-

4,239,533

(983,947)

4,038,281

(983,947)

1,627,063

(793,711)

5,665,344

(1,777,658)

Dividend paid to owners for 2024/25

-

-

-

-

(737,960)

(737,960)

(1,208,300)

(1,946,260)

Adjustment for Investment property

-

-

-

(136,287)

-

(136,287)

-

(136,287)

Share issue to IFC

-

-

-

-

-

-

3,270,000

3,270,000

Share issue cost to IFC

-

-

-

-

(60,658)

(60,658)

-

(60,658)

Share isuued by Lina Manufacturing Pvt Ltd to NCI

-

-

-

-

256,827

256,827

Reversal of Dividend payable

-

-

-

-

7,680

7,680

7,680

Equity adjustment on changes in holding in Lina Manufacturing Pvt Ltd

-

-

-

-

16,390

16,390

(16,390)

-

WHT payment on dividend distribution

-

-

-

-

(749,297)

(749,297)

(155,168)

(904,465)

Balance as at 31st March 2025

4,240,394

1,190

1,258

291,328

15,965,699

20,299,026

6,748,189

27,047,215

The above figures are not audited

Page 07



SUNSHINE HOLDINGS PLC

FOR THE YEAR ENDED 31ST MARCH 2025

STATEMENT OF CHANGES IN EQUITY - COMPANY

In RS '000

Stated

capital

Fair valuegain or loss

reserve on AFS

General

reserve

Retained

earnings

Total

Balance as at 1 April 2023

4,240,394

183,012

1,258

4,638,236

9,062,900

Amalgamation adjustment

-

-

-

104,296

104,296

Adjusted balance as at 1st April 2023

4,240,394

183,012

1,258

4,742,533

9,167,196

Total comprehensive income for the year

Profit for the year

-

-

-

2,004,522

2,004,522

Total other comprehensive income for the year

-

246,320

-

-

246,320

Total comprehensive income for the year

-

246,320

-

2,004,522

2,250,842

Amalgamation adjustment

15,034

15,034

Dividend to owners - 2022/23

-

-

-

(565,770)

(565,770)

Dividend to owners - 2023/24

-

-

-

(491,974)

(491,974)

Balance as at 31st March 2024

4,240,394

429,332

1,258

5,689,311

10,360,294

Balance as at 1 April 2024

4,240,394

429,332

1,258

5,689,311

10,360,294

Total comprehensive income for the period

Profit for nine months

-

-

-

2,243,695

2,243,695

Total other comprehensive income for the year

-

(144,325)

-

-

(144,325)

Total comprehensive income for the year

-

(144,325)

-

2,243,695

2,099,370

Dividend to owners - 2023/24

-

-

-

(983,947)

(983,947)

Dividend to owners - 2024/25

-

-

-

(737,960)

(737,960)

Balance as at 31st March 2025

4,240,394

285,007

1,258

6,211,099

10,737,757

The above figures are not audited

Page 08



SUNSHINE HOLDINGS PLC

Unaudited

Audited

STATEMENT OF CASH FLOWS - GROUP

Year ended 31 March 2025

Year ended 31 March 2024

RS '000

RS '000

CASH FLOWS FROM OPERATING ACTIVITIES

Profit before income tax

8,970,845

8,071,886

Adjustments for;

Interest Income

(390,506)

(525,313)

Profit on Disposal of Property, Plant & Equipment

(80,746)

2,221

Fair value changes in livestock

-

(29,431)

Interest Expense

809,228

980,115

Reversal of Impairement of Investment in Subsidiary Depreciation of Property, Plant and Equipment

-

746,069

Amortization of Intangible Assets

176,423

92,214

Depreciation of mature planations

306,685

179,312

Provision/(Reversal) for Bad and Doubtful Debts

(8,718)

318,629

Provision/ (Reversal) of impairment of inventories

(2,553)

103,939

Amortisation of Deferred Income

20,875

(2,358)

72,565

-

771,098

Amortization of Lesehold land right Fair value gain/loss on investments

(49,464)

76,373

(10,818)

17,536

6,352

Provision for Gratuity excluding acturial gain/loss

216,040

235,618

Fair value gain/loss on Consumer Biological Assets

321,222

(10,558)

Operating profit before working capital changes

11,173,520

10,211,260

(Increase)/decrease in inventories

(1,788,446)

(2,306,107)

(Increase)/decrease in trade and other receivables

(320,797)

(2,208,854)

(Increase)/decrease in amounts due from related parties

(294,607)

117,693

Increase/(decrease) in trade and other payables

1,606,444

1,179,565

Increase/(decrease) in amounts due to related parties

-

(55,000)

Cash generated from/ (used in) operations

10,376,114

6,938,557

Interest paid

(352,110)

(494,687)

Income tax paid

(3,373,543)

(2,226,548)

Gratuity paid

(140,555)

(133,626)

6,509,906

4,083,694

CASH FLOWS FROM INVESTING ACTIVITIES

Interest Received

390,130

525,313

(Investments)/ Disposal in Other Investments

(2,011,109)

882,237

(Investments)/ Disposal in Short term Investments

(491,779)

(1,540,386)

(Investments)/ Disposal in gratuity fund

50,000

9,000

Additions to Bearer plants

(34,077)

(36,021)

Additions of live stock

(186,813)

(306,209)

Acquisition of PPE

(1,010,352)

(709,789)

Acquisition of Intangible Assets

(32,764)

(21,006)

Proceeds from Disposal of PPE

177,961

30,121

Proceeds from sales of livestock

98,682

63,122

Proceeds from share Issued by subsidiaries to NCI

3,209,341

93,000

Disposal of investment property

94,534

-

Acquisition of Investment property

(3,693)

(3,685)

Net cash generated from / (used in) Investing activities

250,061

(1,014,303)

CASH FLOWS FROM FINANCING ACTIVITIES

Receipts of Interest Bearing Borrowings

Proceeds from share Issued by subsidiaries to NCI

20,009,180

-

4,195,897

-

Repayments of Interest Bearing Borrowings

(19,629,452)

(2,958,226)

Payment to lease creditor

(867,763)

(167,853)

Dividend Paid

(3,723,918)

(2,422,963)

Net cash from / (used in) financing activities

(4,211,953)

(1,353,145)

Net increase/(decrease) in cash and cash equivalents

2,548,014

1,716,247

Cash and cash equivalents at the beginning of the period

2,714,544

1,001,633

Effect of exchange rate changes on cash and cash equivalents

(136,287)

(3,335)

Cash and cash equivalents at the end of the period

5,126,271

2,714,544

Cash and cash equivalents

Cash in hand & bank

5,875,414

(2,689,245)

Bank overdraft

(749,144)

5,403,789

5,126,271

2,714,544

Figures in brackets indicate deductions.

The above figures are not audited

Page 09



SUNSHINE HOLDINGS PLC

STATEMENT OF CASH FLOWS - COMPANY

Unaudited

Unaudited

Audited

Period ended

Period ended

Year ended

31st March 2025

LKR '000

31st March 2024

RS '000

31st March 2024

LKR '000

CASH FLOWS FROM OPERATING ACTIVITIES

2,210,772

1,987,233

1,974,740

(96,212)

(159,616)

(159,616)

Profit before income tax Adjustments for; Interest income

Interest expense

4,321

21,588

1,218

Amalgamation of SPL

-

-

-

Fair Value of Investment property

(56,072)

-

(56,072)

Impairment of Intercompany Loan

-

-

14,000

Impairement of Investment in Subsidiary

-

-

1,034

Depreciation of Property, Plant and Equipment 36,525

Amortization of Intangible Assets -

28,112

-

28,113

-

49,429

40,992

40,993

Operating profit before working capital changes

2,148,764

1,931,773

1,913,944

(Increase)/decrease in trade and other receivables

53,940

(19,383)

(15,883)

(Increase)/Decrease in Inventory

296

1,587

1,587

(Increase)/decrease in amounts due from related parties

16,733

(24,038)

(38,122)

Increase/(decrease) in trade and other payables

93,621

59,875

63,187

Increase/(decrease) in amounts due to related parties

(280)

269

269

Cash generated from/ (used in) operations

2,313,074

1,926,085

1,924,982

Interest paid

(4,321)

(6,023)

(270)

Income tax paid

(22,101)

-

-

Employee benefits paid

(523)

-

-

Net cash generated from / (used in) operating activities

2,286,129

1,920,061

1,914,712

CASH FLOWS FROM INVESTING ACTIVITIES

Interest received

100,473

153,359

153,359

Investments in subsidiaries

-

(500,000)

(500,000)

(Investments)/ Disposal of Quoted shares

7,549

-

-

(Investments)/ Disposal of Quoted shares

(14,634)

-

-

Acquisition of Investement Property

-

(3,680)

-

Disposal of Subsidiary (net of cash)

-

-

-

Proceeds on disposal of shares held in subsidiary

(Investments)/ Disposal in Short term Investments

(1,041,510)

(574,364)

(574,364)

(Investments)/ disposal in other investments

-

-

-

Acquisition of intangible assets

(610)

-

-

Proceed from disposal of property, plant & equipment

737

-

-

Acquisition of property, plant & equipment

(34,706)

(5,973)

(5,973)

Net cash used in investing activities

(982,700)

(930,657)

(926,978)

CASH FLOWS FROM FINANCING ACTIVITIES

Payment of lease liabilities

(27,163)

(20,724)

(20,724)

Dividend paid

(1,721,908)

(1,057,744)

(1,057,744)

Net Cash generated from / (used in) Financing Activities

(1,749,071)

(1,078,468)

(1,078,468)

Net increase/(decrease) in cash and cash equivalents

(445,643)

(89,069)

(90,733)

Cash and cash equivalents at the beginning of the period

734,571

823,640

814,025

Cash and cash equivalents at the end of the period

288,928

734,571

723,292

Cash and cash equivalents

Cash in hand & bank

288,928

734,571

723,291

Bank overdraft

-

-

-

Fair value gain/ loss in quoted shares and unit trust

- 13,462

13,462

Provision for gratuity

Figures in brackets indicate deductions. The above figures are not audited

288,928 734,571 723,291

Page 10



SUNSHINE HOLDINGS PLC SEGMENTAL ANALYSIS

FOR THE QUARTER ENDED 31ST MARCH 2024

Healthcare Agri Consumer Goods

Other Intragroup Group

Restated Restated Restated

RS '000

RS '000

RS '000

RS '000

RS '000

RS '000

RS '000

RS '000

RS '000

RS '000

RS '000

RS '000

2025

2024

2025

2024

2025

2024

2025

2024

2025

2024

2025

2024

REVENUE

32,586,050

27,772,530

7,944,206

8,320,903

18,746,678

19,323,519

3,674,783

2,072,149

(3,669,471)

(2,066,954)

59,282,247

55,422,147

RESULT

Profit from operating activities

5,518,303

4,298,826

2,873,943

2,660,713

1,150,449

1,873,889

5,067,236

3,426,998

(5,331,466)

(3,598,034)

9,278,463

8,662,393

Net finance cost

(189,351)

(520,419)

24,579

105,132

(254,590)

(340,127)

104,498

161,628

7,248

-

(307,617)

(590,506)

Income tax expense

(1,750,515)

(1,249,614)

(1,013,613)

(421,110)

(312,507)

(389,709)

19,916

7,794

-

-

(3,056,720)

(2,052,638)

Profit for the year

3,578,437

2,528,793

1,884,909

2,344,736

583,351

1,144,053

5,191,650

761,169

(5,299,328)

(3,598,034)

5,914,127

6,019,249

Other comprehensive income

(27,548)

(11,913.92)

(69,880)

(10,699.69)

(7,030)

8,178

(144,325)

246,320

-

-

(248,782)

231,885

Total comprehensive income

3,550,889

2,516,879

1,815,029

2,334,036

576,321

1,152,231

5,047,325

761,169

(5,324,218)

(3,598,034)

5,665,345

6,251,133

OTHER INFORMATION

Healthcare Agri Consumer Goods Other

RS '000

RS '000

RS '000

RS '000

RS '000

RS '000

RS '000

RS '000

RS '000

RS '000

RS '000

RS '000

31/03/2025

31/3/2024

31/03/2025

31/3/2024

31/03/2025

31/3/2024

31/03/2025

31/3/2024

31/03/2025

31/3/2024

31/03/2025

31/3/2024

Segment assets

25,004,337

20,666,686

8,713,149

9,431,315

9,719,932

9,079,745

15,956,259

15,341,389

(11,240,250)

(11,047,156)

48,153,426

43,471,979

Equity & reserves

14,086,040

8,455,982

3,747,238

6,397,322

4,966,815

3,930,451

15,437,078

14,633,543

(11,189,959)

(10,744,607)

27,047,215

22,672,693

Total liabilities

10,918,297

12,210,704

4,965,911

3,033,993

4,753,117

5,149,294

519,182

707,846

(50,291)

(302,549)

21,106,211

20,799,286

RS '000

RS '000

RS '000

RS '000

RS '000

RS '000

RS '000

RS '000

RS '000

RS '000

RS '000

RS '000

2025

2024

2025

2024

2025

2024

2025

2024

2025

2024

2025

2024

Depreciation

324,000

327,656

419,905

411,783

234,433

247,823

40,281

29,430

-

-

1,018,618

1,016,692

Capital expenditure

746,295

290,026

444,902

697,593

235,408

174,229

90,815

5,914

-

-

1,517,421

1,167,762

Figures in brackets indicate deductions

.

The above figures are not audited

Page 11



SUNSHINE HOLDINGS PLC NOTES TO THE ACCOUNTS

  1. Corporate information

    Sunshine Holdings PLC (the "Company") is a Company incorporated and domiciled in Sri Lanka. The ordinary shares of the Company are listed on Colombo Stock Exchange of Sri Lanka. The address of the Company's registered office is no. 60, Dharmapala Mawatha, Colombo 03, Sri Lanka.

    The Group is primarily involved in managing portfolio of investments which includes manufacturing, importing and selling of pharmaceuticals & medical devices, selling and export of branded tea, manufacturing of confectionery, fresh milk, palm oil and related products.

  2. Interim condensed financial statements

    The Interim Condensed Financial Statements for the year ended 31st March 2025, includes the "Company" referring to Sunshine Holdings PLC as the holding Company and the "Group" comprise the Company and subsidiary companies of Sunshine Consumer Lanka Limited (SCL) and its subsidiaries, Sunshine Healthcare Lanka Limited (SHL) and its subsidiaries, and its subsidiary, Sunshine Wilmar (Pvt) Ltd (SWPL) and its subsidiaries.

    The ultimate parent of the company is Lamurep Investments Limited which holds 55.18% of the issued share capital of the company as at 31st March 2025.

  3. Approval of financial statements

    The Interim Condensed Financial Statements of the Group and the Company for the period ended 31st March 2025, were authorised for issue by the Board of Directors on 28th May 2025.

  4. Basis of preparation

    The Interim Condensed Consolidated Financial Statements have been prepared in accordance with the Sri Lanka Accounting Standards with effect from 01 January 2014 (SLFRS/LKAS). There were no changes to the accounting policies and methods of computation since the publication of the Annual Report 2023/24. Further, these Financial Statements have been prepared in compliance with the requirement of the Sri Lanka Accounting Standard - LKAS 34 on "Interim Financial Reporting".

    The Interim Condensed Consolidated Financial Statements do not include all the information and disclosures required in the Annual Financial Statements, and should be read in conjunction with the Group's annual Consolidated Financial Statements as at 31 March 2024.

    Previous period figures and phrases have been rearranged

    wherever necessary to conform to the current presentation.

  5. Significant Accounting Policies

    The accounting policies applied in these interim financial statements are the same as those applied in the Group's consolidated financial statements as at and for the year ended 31 March 2024.

    1. Standards Issued but not yet Effective

      A number of new standards and amendments to standards are

      effective for annual periods beginning after 1 April 2024 and early

      application is permitted; however the Group has not early adopted any of the forthcoming new or amended standards in preparing these condensed consolidated interim financial statements.

    2. Basis of Consolidation

      Subsidiaries are those entities controlled by the Group. Control is the power to govern the financial and operating policies of an entity so as to obtain benefits from its activities. In assessing control, the Group takes in to consideration that substantive rights that give the ability to direct the activities of the subsidiaries.

      The Financial Statements of the subsidiaries are included in the Consolidated Financial Statements from the date the control effectively commences until the date that control effectively ceases. Non- controlling interest is measured at the proportionate share of the acquiree's identifiable net assets. A change in the ownership interest of a subsidiary, without a loss of control, is accounted for as an equity transaction.

    3. Use of judgements and estimates

      In preparing these interim condensed financial statements, management has made judgements and estimates that affected the application of accounting policies and the reported amounts of assets and liabilities, income and expenses. Actual results may differ these estimates.

      The significant judgments made by management in applying the Group's accounting policies and the key sources of estimation uncertainty were the same as those described in the last annual financial statements.

    4. Property, Plant & equipment Recognition and measurement

      Property, plant and equipment is recorded at cost less accumulated depreciation and accumulated impairment losses if any, whilst land is measured at fair value.

      De-recognition

      The carrying amount of an item of Property, plant & equipment is de-recognised on disposal; or when no future economic benefits are expected from its use. Gains and losses on de-recognition are recognised in income statement and gains are not classified as revenue. When re-valued assets are sold, any related amount included in the revaluation reserve is transferred to Retained Earnings.

      Depreciation

      Depreciation is recognised in income statement on a straight-line basis over the estimated useful lives of each part of an item of property, plant & equipment.

      1. Impairment

        The Board of Directors has assessed the potential impairment loss of the property, plant and equipment as at 31 March 2025. Based on the assessment, no impairment provision is required to be made in the financial statements as at the reporting date.

    5. Biological assets

      The Group recognise the biological assets when, and only when,

      Page 12



      SUNSHINE HOLDINGS PLC NOTES TO THE ACCOUNTS

      the Company controls the assets as a result of past events, it is probable that future economic benefits associated with the assets will flow to the entity and fair value or cost of the assets can be measured reliably.

      Bearer biological assets

      Tea, rubber, oil palm, cinnamon ,sundry crops and nurseries are classified as bearer biological assets. The bearer biological assets are measured at cost less accumulated depreciation and accumulated impairment losses, if any, in terms of Sri Lanka Accounting Standard LKAS 16 - Property Plant and Equipment as per the ruling issued by Institute of Chartered Accountants of Sri Lanka.

      Consumable biological assets

      Timber plantation is classified as consumable biological assets and is measured on initial recognition and at the end of each reporting period at fair value less cost to sell. Costs to sell include all costs that would be necessary to sell the assets, including transportation costs. The fair value of trees younger than five years cannot be reliably estimated and are carried at cost less impairment. The cost includes direct material, direct labour and appropriate proportion of directly attributable overheads. Gains or losses arising on initial recognition of timber plantations at fair values less costs to sell and from the change in fair values less costs of plantations at each reporting date are included in profit or loss for the period in which they arise. All costs incurred in maintaining the assets are included in Profit or Loss for the period in which they arise.

      Livestock

      Livestock is measured at their fair value less estimated point of sale costs. Changes in fair value of livestock are recognised in the income statement.

    6. Investment properties

      Investment properties are measured initially at cost, including transaction costs. The carrying value of an investment property includes the cost of replacing part of an existing investment property, at the time that cost is incurred if the recognition criteria are met, and excludes the costs of day to- day servicing of the investment property. Subsequent to initial recognition, the investment properties are stated at fair values, which reflect market conditions at the reporting date. Gains or losses arising from changes in fair value are included in the income statement in the year in which they arise. Fair values are evaluated at least every 3 years by an accredited external, independent valuer. Investment properties are derecognised when disposed, or permanently withdrawn from use because no future economic benefits are expected. Any gains or losses on retirement or disposal are recognised in the income statement in the year of retirement or disposal.

      5.7 Inventories

      Inventoraies other than produce stock and nurseries are stated at the lower of cost or net realisable value, after making due allowances for obsolete and slow moving items. The Group uses weighted average cost formula and actual cost in assigning the cost of inventories. The cost includes expenses in acquiring stocks, production and conversion cost and other costs incurred in bringing them to their existing location and condition.

  6. Revenue

    Revenue recognition under SLFRS 15 is based on the nature and timing of satisfaction of performance obligations, including significant payment terms.

    SLFRS 15 - Revenue from contracts with customers, establishes a comprehensive framework for determining whether, how much and when revenue is recognised. The Group recognises revenue when a customer obtains control of the goods or services. Judgement is used to determine the timing of transfer of control -at a point in time or over the time.

    1. Shared Service Income

      Presently the company's primary business activity is providing shared services to the group. Accordingly company has reclassified the revenue stream. This change aligns with the Company's evolving business model and provides a clearer and more accurate representation of its business activities. Accordingly, Rs. 723Mn (2023/24 - Rs. 453 Mn) shared service charge has been identified as revneue of the company. The dividend income of Rs.2,395 Mn (2023/24 - 2,070 Mn ) has been recognized under other income.

    2. Agri Business

      Customers obtain the control of the produce after the customer acknowledgement at the dispatch point. Revenue is recognized point in time, at the time of dispatch after the customer acknowledgement.

    3. Consumer

      Customers obtain control of the goods sold when the goods are delivered to and have been accepted at their premises. Invoices are generated at that point in time. Revenue is recognized when a customer obtains control of the goods or services. Determining the timing of the transfer of control is at a point in time.

    4. Healthcare

      Customers obtain control of the goods sold when the goods are delivered to and have been accepted at their premises. Invoices are generated at that point in time. Revenue is recognized when a customer obtains control of the goods or services. Determining the timing of the transfer of control is at a point in time.

    5. Sunshine Tea

      This includes income of tea export to different countries. Revenue is recognised point in time, at the time of dispatch after the customer acknowledgement.

    6. Rent income

    This includes rental income earned from renting out investment property owned by the Company and it's Subsidiary. Revenue is recognized over time as the rent income is recognized on a straight line basis over the term of the agreement.

    6.1 Disaggregation of Revenue from Contracts with Customers

    The disaggregation of revenue has been provided under segmental analysis.

  7. Investments in subsidiaries

Quoted and unquoted investments in shares held on long term basis by the Company and Group are stated at cost less provision for diminution in value of investments.

Page 13



SUNSHINE HOLDINGS PLC NOTES TO THE ACCOUNTS

  1. Change In NCI during FY 2023/24

    Below NCI changes have been occurred during FY 2023/24.

    On August 03, 2023, LMPL, which is a subsidiary of SHL, became a 100% ownership of Lina Spiro (Private) Limited (LSPL) with the acquisition of remaining Non-Controlling Interest of 49%. The consideration for this purchase was satisfied by the issuance of new ordinary (voting - removed) shares in LMPL to Celogen for a consideration of Rs.307 million. As a result of this transaction, the effective shareholding in LMPL held by the SHL diluted from 90.62% to 71.6%.

  2. Change In NCI during FY 2024/25

On May 6, 2024, International Finance Corporation (IFC) invested a total of LKR 3,269,999,800 in SHL. In consideration of this investment, SHL issued 1,905,239 ordinary voting shares to IFC on October 3, 2024. Following this transaction, SUN now holds 85.27% of the shareholding in SHL, while IFC holds the remaining 14.73%.

On February 6, 2025, Lina Manufacturing (Pvt) Ltd issued 34,253,355 shares to Sunshine Healthcare Lanka Ltd for Rs. 875 million and 10,051,929 shares to Celegon Lanka (Pvt) Ltd for Rs. 257 million. As a result of this transaction, Sunshine Healthcare Lanka Ltd.'s effective shareholding in LMPL increased from 71.6% to 74%.

  1. Investment in a Subsidiary during FY 2023/24

    The board of directors of SUN at the meeting held on 18 January 2024 resolved to infuse a sum of Sri Lanka Rupees Five Hundred Million (Rs. 500,000,000/-) into the capital of it's subsidiary SST. SST accordingly capitalized such sum of Sri Lanka Rupees Five Hundred Million (Rs. 500,000,000/-) by the issue of fully paid ordinary shares to the Company.

  2. Investment in a Subsidiary during FY 2024/25

    On February 6, 2025, Healthguard Pharmacy Ltd issued 12,500,000 shares Sunshine Healthcare Lanka Ltd for Rs. 400 million. Healthguard Pharmacy Ltd. is a fully owned subsidiary of Sunshine Healthcare Lanka Ltd.

  3. Amalgamation of Subsidiary during FY 2023/24

    Gordon Frazer & Bosanquate Skrine company Ltd was amalgamated with SST a fully owned subsidiary of SST with effect from 27 September 2023. Accordingly, the book value of Gordon Frazer & Bosanquate Skrine company Ltd was amalgamated with SST and SST continues as the surviving entity.

  4. Amalgamation of Subsidiary during FY 2024/25

SUN has amalgamated with SPL, a fully owned subsidiary of SUN effective from 01st October 2024.Accordingly, the book value of SPL was amalgamated with SUN and SUN continues as the surviving entity.

On 31st December 2024, SUN has transfered its shareholding in SST, a wholly-owned subsidiary, to SCL, wholly-owned subsidiary of the company. The transaction involves the transfer of 4,716,545 shares in SST, valued at a total consideration of LKR 1,940,000,000. As consideration for the transfer, SCL issued 31,219,826 new shares amounting to LKR 1,940,000,000 to SUN.

Page 14



SUNSHINE HOLDINGS PLC

NOTES TO THE ACCOUNTS

  1. Valuation of Financial Assets and Liabilities

    1. Accounting Classification and Fair Values

The following table shows the carrying amounts and fair values of financial assets and financial liabilities, including their levels in the fair value hierarchy. It does not include fair value infomraton for financial assets and financial liabilities not measured at fair value if the carrying amount is a reasonable approximation of fair value.

The following table shows the carrying amounts and fair values of financial assets and financial liabilities, including their levels in the fair value hierarchy.

GROUP COMPANY

Carrying amount Fair value Carrying amount Fair value

31 March 2025

Classification

(Rs.'000)

Level 1

Level 2

Level 3

Total

(Rs.'000)

Level 1

Level 2

Level 3

Total

Financial Assets measured at Fair value

Investment in Unquoted Shares

Fair value through OCI

468,749

-

-

468,749

468,749

468,749

-

-

468,749

468,749

Investment in Quoted Shares

Fair value through P&L

-

-

-

-

-

-

-

-

-

-

Investment in Unit Trust

Fair value through P&L

4,254,534

4,254,534

-

-

4,254,534

1,655,123

1,655,123

-

-

1,655,123

Investment Fund

Fair value through P&L

5,127

-

5,127

-

5,127

-

-

-

-

-

4,728,409

4,254,534

5,127

468,749

4,728,409

2,123,872

1,655,123

-

468,749

2,123,872

Financial Assets not measured at Fair value

Trade and other receivables **

Amortized cost

9,796,632

-

-

-

9,796,632

18,193

-

-

-

18,193

Investment in Debentures

Amortized cost

104,170

-

-

-

104,170

104,170

-

-

-

104,170

Short term invetsment

Amortized cost

235,000

-

-

-

235,000

235,000

-

-

-

235,000

Amounts due from related parties **

Amortized cost

326,356

-

-

-

326,356

9,459

-

-

-

9,459

Cash & cash equivalents **

Amortized cost

5,875,414

-

-

-

5,875,414

288,928

-

-

-

288,928

16,337,572

-

-

-

16,337,572

655,750

-

-

-

655,750

Financial Liabilities not measured at Fair

value

Loans and borrowings ***

Other financial liabilities

6,870,892

-

-

- 6,870,892

29,763

-

-

- 29,763

Bank overdraft **

Other financial liabilities

749,144

-

-

- 749,144

-

-

-

- -

Trade and other payables **

Other financial liabilities

9,209,949

-

-

- 9,209,949

193,856

-

-

- 193,856

Amounts due to related parties **

Other financial liabilities

-

-

-

- -

2

-

-

- 2

16,829,985

-

-

- 16,829,985

223,621

-

-

- 223,621

GROUP

COMPANY

Fair value Fair value

Carrying amount Carrying amount

31 March 2024 Classification

(Rs.'000)

Level 1

Level 2

Level 3

Total

(Rs.'000)

Level 1

Level 2

Level 3

Total

Financial Assets measured at Fair value

Investment in Unquoted Shares Fair value through OCI

670,469

-

-

670,469

670,469

670,469

-

-

670,469

670,469

Investment in Quoted Shares Fair value through P&L

7,549

7,549

-

-

7,549

7,549

7,549

-

-

7,549

Investment in Unit Trust Fair value through P&L

1,545,256

1,545,256

-

-

1,545,256

621,226

621,226

-

-

621,226

Investment Fund Fair value through P&L

51,393

-

51,393

-

51,393

-

-

-

-

-

2,274,667

1,552,805

51,393

670,469

2,274,667

1,299,244

628,775

-

670,469

1,299,244

Financial Assets not measured at Fair value

Trade and other receivables ** Amortized cost

9,782,520

-

-

9,782,520

44,017

-

44,017

Investment in Debentures Amortized cost

104,206

-

-

104,206

104,206

-

104,206

Short term invetsment Amortized cost

225,000

-

-

225,000

225,000

-

225,000

Amounts due from related parties ** Amortized cost

31,749

-

-

31,749

257,990

-

257,990

Cash & cash equivalents ** Amortized cost

5,403,789

-

-

5,403,789

723,291

-

723,291

15,547,264

-

-

-

15,547,264

1,354,504

-

-

-

1,354,504

Financial Liabilities not measured at Fair value

Loans and borrowings *** Other financial liabilities

6,988,010

-

-

6,988,010

-

-

-

-

Bank overdraft ** Other financial liabilities

2,689,245

-

-

2,689,245

-

-

-

-

Trade and other payables ** Other financial liabilities

7,603,511

-

-

7,603,511

97,345

-

-

97,345

Amounts due to related parties ** Other financial liabilities

-

-

-

-

282

-

-

282

17,280,766

-

-

-

17,280,766

97,627

-

-

97,627

** Classes of financial instruments that are not carried at fair value and of which carrying amounts are a reasonable approximation of fair value. This includes trade receivables, cash and cash equivalents, trade payable, other payables, amounts due to and due from related parties and bank overdraft. The carrying amounts of these financial assets and

liabilities are a reasonable approximation of fair values due to their short term nature.

*** Discounted cash flows: The valuation model considers the present value of expected payments, discounted using a risk-adjusted discount rate.

Page 15



8.2. Measurement of Fair Values

Financial Assets and Liabilities measured or disclosed at Fair Value

The fair value of the financial assets and liabilities is included at the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale.

The Group measures the fair value using the following fair value hierarchy, which reflects the significance of the inputs used in making the measurement. An analysis of the fair value measurement of financial and non-financial assets and liabilities are provided below:

Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities.

When available, the Group measures the fair value of an instrument using active quoted prices or dealer price quotations (assets and long positions are measured at a bid price; liabilities and short positions are measured at an ask price), without any deduction for transaction costs. A market is regarded as active if transactions for asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2: inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices).

This category includes instruments valued using:

  1. quoted prices in active markets for similar instruments,

  2. quoted prices for identical or similar instruments in markets that are considered to be less active, or

  3. other valuation techniques in which almost all significant inputs are directly or indirectly observable from market data.

Level 3: inputs for the asset or liability that are not based on observable market data (unobservable inputs).

This category includes all instruments for which the valuation technique includes inputs not based on observable data and the unobservable inputs have a significant effect on the instrument's valuation.

8.2.a Valuation techniques and significant unobservable inputs

The following valuation techniques used in measuring Level 2 and Level 3 fair values at 31 March 2025 and 31 March 2024 for financial instruments measured at fair value in the statement of financial position, as well as the significant unobservable inputs used.

Unquoted equity instruments - Discounted cash flows

The valuation model considers the present value of expected net cash flows from those investments discounted using a risk adjusted discount rate. The expected cash flows are derived based on the budgeted cash flow forecasts of those investments determined by considering the sensible probability of the forecast EBITDA.

Interest rate swaps/Cross currency swaps - Swap models

The fair value is calculated as the present value of the estimated future cash flows. Estimates of future floating-rate cash flows are based on quoted swap rates, futures prices and interbank borrowing rates. Estimated cash flows are discounted using a yield curve constructed from similar sources and which reflects the relevant benchmark interbank rate used by market participants for this purpose when pricing interest rate swaps. The fair value estimate is subject to a credit risk adjustment that reflects the credit risk of the Group and of the counterparty; this is calculated based on credit spreads derived from current credit default swap or bond prices.

Those assumptions for assets categorised as Level 3 has been described under respective notes to the financial Statements as at 31 March 2024.

During the reporting period ended 31 March 2025 and 31 March 2024, there were no transfers between Level 1 and Level 2 fair value measurements.

Page 16



SUNSHINE HOLDINGS PLC NOTES TO THE ACCOUNTS

  1. Comparatives

    The presentation and classification of the Financial Statements of the previous periods have been amended, where relevant, for better presentation and

    to be comparable with those of the current period.

  2. Stated capital is represented by shares in issue as given below:

    No. of shares as at

    31st March 2025

    31 March 2024

    Ordinary shares

    1,967,894,516

    491,973,629

    SUN has subdivided the ordinary shares of the Company, amounting to four hundred and ninety one million nine hundred and seventy three thousand six hundred and twenty nine (491,973,629) ("Pre-Subdivision Shares") into one billion nine hundred and sixty seven million eight hundred and ninety four thousand five hundred and sixteen (1,967,894,516) ordinary shares ("Post-Subdivision Shares") on the basis of one (01) Pre-Subdivision share held by each shareholder into four (4) ordinary shares.

  3. Dividend

    2024/25 (Interim)

    RS '000

    2023/24 (Final)

    RS '000

    2023/24 (Interim)

    RS '000

    Dividend (Rs)

    737,060

    983,947

    491,974

    No of ordinary shares

    491,974

    491,974

    491,974

    Dividend per share (cash

    - After share subdivision)

    0.38

    0.50

    0.25

  4. Commitments & contingencies

    There has not been significant change in the nature of the contingent liabilities, which were disclosed in the Annual Report for the year ended 31st

    March 2024.

  5. Income tax

    Tax expense comprises current and deferred tax. Current tax and deferred tax are recognized in Statement of Profit or Loss except to the extent that it

    relates to a business combination, or items recognized directly in equity or in Other Comprehensive Income.

    The Group has determined that interest and penalties relating to income taxes, including uncertain tax treatments, do not meet the definition of income taxes, and therefore accounted for them under LKAS 37 Provisions, Contingent Liabilities and Contingent Assets.

  6. Earnings per share

    The earnings per share is computed on the profit attributable to ordinary shareholders after tax and non-controlling interest divided by the number of ordinary shares as at the reporting date. Further there was no dilution of ordinary shares outstanding at any time during the period. Therefore, diluted earnings per share is the same as basic earning per share.

  7. Net Assets per share

    Net assets per share has been calculated, for all periods, based on the number of shares issued as at the reporting date.

  8. The interim Financial Statements are not audited.

Page 17



SUNSHINE HOLDINGS PLC

NOTES TO THE ACCOUNTS

SHAREHOLDER INFORMATION

Audited

Market price per share

Period ended

Year ended

31st March 2025

31st March 2024

Highest price

Rs.

100.75*

Rs.

61.50 *

Lowest price

19.80

50.00 *

Last traded price

21.50

59.50 *

TWENTY (20) LARGEST SHAREHOLDERS AS AT

31 March 2025

Name

No of Shares

%

Held

1. Lamurep Investments Limited Account No.04 & 01

1,085,816,556

55.18%

2. Akbar Brothers Pvt Ltd A/C No 1

196,967,420

10.01%

3. Deepcar Limited

185,056,304

9.40%

4. Citibank Newyork S/A Norges Bank Account 2

52,918,548

2.69%

5. Ceylon Property Development Limited

43,663,504

2.22%

6. Thread Capital (Private) Limited

35,779,668

1.82%

7. Mr. V.Govindasamy

24,318,000

1.24%

8. Seylan Bank PLC/ Mohamed Nayazdeen

23,323,492

1.19%

9. Perera And Sons Bakers Pvt Limited

17,600,000

0.89%

10. Rubber Investment Trust Ltd A/C No 01

14,158,916

0.72%

11. Mr.Hanif Yusoof & NDB Wealth Management

13,267,979

0.67%

12. Ranavav Holdingd (Pvt) Ltd & Ranavav Holdings (Pvt) Ltd

10,946,824

0.56%

13. Ceylon Guardian Investment Trust PLC A/C # 02

9,977,108

0.51%

14. Asia Securities (Pvt) Ltd (Trading Account)

9,322,880

0.47%

15. DFCC Bank PLC A/C/ No 2 & A/C/No 1

6,930,120

0.35%

16. Union Assurance PLC - Universal Life Fund

6,801,967

0.35%

17. Ceylon Investment PLC A/C 02

6,520,000

0.33%

18. AFC Umbrella Fund- AFC Asia Frontier Fund

5,996,044

0.30%

19. Invenco Capital Private Limited

5,114,819

0.26%

20. National Savings Bank

4,897,842

0.25%

Sub Total

1,759,377,991

89.40%

Others

208,516,525

10.60%

Total

1,967,894,516

100.00%

PUBLIC SHARE HOLDING

Requirement by CSE

As at 31 December 2024

Option

3

3

Float adjusted market capitalization

Above Rs.5,000,000,000/-

15,423,373,269

The percentage of shares held by the public

7.5%

31.35%

Number of shareholders representing public holding

500

7,000

The number of shares held by the Board of Directors are as follows:

As at

As at

31st March 2025

31st March 2024

Mr. V. Govindasamy

24,318,000

6,079,500 *

Mr.G.Sathasivam

36,660

9,165 *

Mr. S.G. Sathasivam

12,216

3,054 *

* Figures indicated the results prior to the share subdivision.

Page 18



CORPORATE INFORMATION

Name of Company

Sunshine Holdings PLC

Legal Form

Public Limited Liability Company

(Incorporated in 1973 and listed in the Colombo Stock Exchange)

Company Registration Number

PQ13

Principal Activities

Managing a portfolio of businesses

Registered Office

No. 60, Dharmapala Mawatha, Colombo 03

Directors

Mr. D. A. Cabraal Mr. V. Govindasamy Mr. S.G. Sathasivam

Mr. A. Talwatte (Resigned with effect from 1st of April 2025)

Mr. G. Sathasivam Mr. S. Shishoo

Mr. Sudarshan Jain Mr. S. Renganathan

Mr. Tyeabally Akbarally Mr. Reyaz Mihular

Ms. Aruni Goonetilleke Mr. Aruna Deepthikumara

Secretaries

Corporate Services (Private) Limited No. 216, De Seram Place,

Colombo 10

Tel: 011 4 605 100

Auditors

KPMG

Chartered Accountants

32A, Sri Mohamed Macan Marker Mawatha, Colombo 03

Lawyers

F J & G de Saram (Attorney- at -Law) No.216, de Saram Place

Colombo 10

Nithya Partners Attorneys-at-Law No. 97/A, Galle Road Colombo 03

Bankers

Hatton National Bank PLC National Development Bank PLC MCB Bank Limited

Standard Chartered Bank Ltd. Seylan Bank PLC

Nations Trust Bank PLC Commercial Bank PLC Indian Overseas Bank

Hongkong and Shanghai Banking Corporation Limited DFCC Bank PLC

Indian Bank

Credit Ratings

The Company has been assigned a national long-term rating of 'AA+(lka)'; outlook stable by Fitch Ratings

Lanka Limited

Page 19



Company analysis

Earlier from Sunshine

All Sunshine news releases